SALT treatment for liver cirrhosis
Part of Digestive system clinical trials.
This trial tests a treatment called SALT for people with liver cirrhosis caused by hepatitis B. It aims to see if it can improve liver function and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a history of hepatitis B infection.
- Your imaging shows signs of liver cirrhosis.
- You have had at least one of these complications: a MELD score of 15–40, bleeding from enlarged veins in the food pipe or stomach, fluid build-up in the belly that does not go away, repeated confusion from liver failure, kidney problems from liver disease, or low oxygen levels due to liver disease.
- You are able to care for yourself and do most normal activities (PS score 0–1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a liver transplant to people with cirrhosis and small liver tumors from hepatitis B can help them live longer. It compares outcomes for patients who meet specific tumor size criteria.
This trial is testing a new way to screen for liver cancer in people with cirrhosis or chronic hepatitis B. It aims to find cancer earlier so it can be treated more effectively.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This study is looking at a new way to treat severe liver disease in young people when a regular liver transplant isn't possible. It might help if your liver is failing and you can't get a transplant from a donor.
This trial is testing a new approach for people whose colorectal cancer has spread to the liver and cannot be removed by surgery. The treatment involves a liver transplant, so it is for patients whose tumors are stable or improving after chemotherapy and have not spread beyond the liver (or have only a few removable lung spots). It aims to improve outcomes for patients with limited options.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.